Rossari Biotech Limited

NSEI:ROSSARI Stock Report

Market Cap: ₹43.5b

Rossari Biotech Dividends and Buybacks

Dividend criteria checks 0/6

Rossari Biotech is a dividend paying company with a current yield of 0.064%.

Key information

0.06%

Dividend yield

-0.06%

Buyback Yield

Total Shareholder Yield0.003%
Future Dividend Yield0.3%
Dividend Growth5.9%
Next dividend pay daten/a
Ex dividend daten/a
Dividend per share₹0.500
Payout ratio2%

Recent dividend and buyback updates

Recent updates

Why We Think Rossari Biotech Limited's (NSE:ROSSARI) CEO Compensation Is Not Excessive At All

Aug 17
Why We Think Rossari Biotech Limited's (NSE:ROSSARI) CEO Compensation Is Not Excessive At All

Is Rossari Biotech (NSE:ROSSARI) Using Too Much Debt?

Jun 14
Is Rossari Biotech (NSE:ROSSARI) Using Too Much Debt?

Rossari Biotech's (NSE:ROSSARI) Solid Profits Have Weak Fundamentals

May 07
Rossari Biotech's (NSE:ROSSARI) Solid Profits Have Weak Fundamentals

Analyst Estimates: Here's What Brokers Think Of Rossari Biotech Limited (NSE:ROSSARI) After Its Annual Report

May 03
Analyst Estimates: Here's What Brokers Think Of Rossari Biotech Limited (NSE:ROSSARI) After Its Annual Report

One Analyst Just Shaved Their Rossari Biotech Limited (NSE:ROSSARI) Forecasts Dramatically

Feb 10
One Analyst Just Shaved Their Rossari Biotech Limited (NSE:ROSSARI) Forecasts Dramatically

Returns On Capital At Rossari Biotech (NSE:ROSSARI) Paint A Concerning Picture

Sep 23
Returns On Capital At Rossari Biotech (NSE:ROSSARI) Paint A Concerning Picture

Returns On Capital Signal Tricky Times Ahead For Rossari Biotech (NSE:ROSSARI)

Apr 06
Returns On Capital Signal Tricky Times Ahead For Rossari Biotech (NSE:ROSSARI)

Need To Know: Analysts Are Much More Bullish On Rossari Biotech Limited (NSE:ROSSARI) Revenues

Feb 19
Need To Know: Analysts Are Much More Bullish On Rossari Biotech Limited (NSE:ROSSARI) Revenues

Rossari Biotech Limited Just Beat Revenue Estimates By 6.8%

Feb 17
Rossari Biotech Limited Just Beat Revenue Estimates By 6.8%

I Ran A Stock Scan For Earnings Growth And Rossari Biotech (NSE:ROSSARI) Passed With Ease

Feb 10
I Ran A Stock Scan For Earnings Growth And Rossari Biotech (NSE:ROSSARI) Passed With Ease

Capital Allocation Trends At Rossari Biotech (NSE:ROSSARI) Aren't Ideal

Nov 24
Capital Allocation Trends At Rossari Biotech (NSE:ROSSARI) Aren't Ideal

With EPS Growth And More, Rossari Biotech (NSE:ROSSARI) Is Interesting

Oct 12
With EPS Growth And More, Rossari Biotech (NSE:ROSSARI) Is Interesting

Is Rossari Biotech Limited's (NSE:ROSSARI) Latest Stock Performance Being Led By Its Strong Fundamentals?

Dec 17
Is Rossari Biotech Limited's (NSE:ROSSARI) Latest Stock Performance Being Led By Its Strong Fundamentals?

Rossari Biotech (NSE:ROSSARI) Is Growing Earnings But Are They A Good Guide?

Oct 26
Rossari Biotech (NSE:ROSSARI) Is Growing Earnings But Are They A Good Guide?

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: ROSSARI is not paying a notable dividend for the Indian market, therefore no need to check if payments are stable.

Growing Dividend: ROSSARI is not paying a notable dividend for the Indian market, therefore no need to check if payments are increasing.


Dividend Yield vs Market

Rossari Biotech Dividend Yield vs Market
How does ROSSARI dividend yield compare to the market?
SegmentDividend Yield
Company (ROSSARI)0.06%
Market Bottom 25% (IN)0.2%
Market Top 25% (IN)1.1%
Industry Average (Chemicals)0.7%
Analyst forecast (ROSSARI) (up to 3 years)0.3%

Notable Dividend: ROSSARI's dividend (0.064%) isn’t notable compared to the bottom 25% of dividend payers in the Indian market (0.24%).

High Dividend: ROSSARI's dividend (0.064%) is low compared to the top 25% of dividend payers in the Indian market (1.11%).


Earnings Payout to Shareholders

Earnings Coverage: ROSSARI is not paying a notable dividend for the Indian market.


Cash Payout to Shareholders

Cash Flow Coverage: ROSSARI is not paying a notable dividend for the Indian market.


Discover strong dividend paying companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 22:11
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Rossari Biotech Limited is covered by 5 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullAnand Rathi Shares and Stock Brokers Limited
Bhawana IsraniAnand Rathi Shares and Stock Brokers Limited
Rohit NagrajCentrum Broking Limited